DJIA 17,778.15 421.28 2.43%
NASDAQ 4,748.40 104.08 2.24%
S&P 500 2,061.23 48.34 2.40%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

168.48 5.00 (3.06%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $168.48 3.06%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $166.10
Previous Close $163.48
Daily Range $164.58 - $168.59
52-Week Range $108.20 - $173.14
Market Cap $128.2B
P/E Ratio 25.74
Dividend (Yield) $2.44 (1.5%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,493,819
Average Daily Volume 3,260,154
Current FY EPS $8.58





Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary

Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson

Novartis AG and Amgen Inc. have promising new psoriasis drugs that could challenge Johnson & Johnson's Stelara for market share.

Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog

Daily Dividend Report: AMGN, ZTS, WDR, IRC, SCHL, KYE

DirecTV Leads The 20 Best Value Bond Trades With Maturities Of 1 Year Or More

Novartis Successfully Expands Signifor Label in the U.S. - Analyst Blog

Is a Biosimilar (Generic) Top Cancer Drug for You?

A 'Wisdom Of Experts' Portfolio

Alkermes Starts Phase I Study on Schizophrenia Candidate - Analyst Blog

Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog

Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog

My Strategy For Objective, Emotionless Dividend Growth Investing, Part 4

Amgen: Assessing The Split Up Value

See More AMGN News...

AMGN's Top Competitors

AMGN $168.48 (3.06%)
Current stock: AMGN
GILD $105.54 (3.07%)
Current stock: GILD
CELG $116.48 (3.24%)
Current stock: CELG
$0.00 (0.00%)
Current stock: